CryoLife, a provider of biomaterials and a tissue processing services as well as a developer of medical devices, is teaming with the Cleveland Clinic to develop heart valves for use in patients who suffer from serious heart infections.

The valves will be made from allograft, or human tissue. They are to be designed to help patients suffering from infective endocarditis.

Jose Navia, a cardiac surgeon with the Heart and Vascular Institute at Cleveland Clinic, will work with CryoLife to develop the valves and implantation techniques.

Navia, a paid consultant of CryoLife, is already seeking patent protection for tissue preparation and valve implantation techniques that he has developed.